[1] 张陈平.口腔癌治疗规范的思考[J].中国肿瘤临床,2010,37(16)∶905-907 [2] Zhang SK, Zheng RS, Chen Q, et al. Oral cancer incidence and mortality in China, 2011 [J]. Chin J Cancer Res,2015,27(1)∶44-51 [3] Hafed L, Farag H, Shaker O, et al. Is human papilloma vi-rus associated with salivary gland neoplasms? An in situ-hy-bridization study [J]. Arch Oral Biol,2012,57(9)∶1194-1199 [4] Asiaf A, Ahmad ST, Mohammad SO, et al. Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection [J]. Eur J Cancer Prev, 2014, 23(3)∶206-224 [5] 王军,张宏,宋一丁,等.HPV感染与头颈部鳞癌的关系[J].甘肃医药, 2017,36(9)∶718-721 [6] 张春林,陈月红,邓泽义,等.中国口腔癌中高危型HPV感染率的Meta分析[J].中华肿瘤防治杂志,2016,23(10)∶682-689 [7] 左晶晶,陈晨,曾曼丽,等.吸烟与癌症相关性的研究进展[J].现代生物医学进展,2017,17(16)∶3180-3183 [8] Galeone C, Edefonti V, Parpinel M, et al. Folate intake and the risk of oral cavity and pharyngeal cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology Consortium [J]. Int J Cancer,2015,136(4)∶904-914 [9] 于世凤.口腔组织病理学[M].第6版. 北京:人民卫生出版社,2010.349 [10] 狄辉.饮酒与口腔鳞状细胞癌关系的Meta分析[J].浙江医学,2013,35(14)∶1371-1373 [11] Walvekar RR, Chaukar DA, Deshpande MS, et al. Verrucous carcinoma of the oral cavity: a clinical and pathological study of 101 cases [J]. Oral Oncol,2009,45(1)∶47-51 [12] Yoon HH,Sukov WR,Shi Q,et al. HER-2/neu gene amplification in relation to expression of HER2 and HER3 proteins in patients with esophageal adenocarcinoma [J]. Cancer,2014,120(3)∶415-424 [13] Mahlknecht G,Maron R,Mancini M,et al. Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth [J].Proc Natl Acad Sci U S A,2013,110(20)∶8170-8175 [14] 邓巍,谢洪,孙晓菊.口腔鳞状细胞癌C-erbB-2蛋白表达 基因扩增及其临床意义[J].中国实用口腔科杂志,2014,7(5)∶290-293 [15] Breuer RH, Snijders PJ, Smit EF, et al. Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis[J]. Neoplasia, 2004, 6(6)∶736-738 [16] 姚冬颖.食管鳞癌组织中Bmi-1、P16和CyclinD1的表达及临床意义[J].中国老年学杂志,2015,11(35)∶6352-6353 [17] Kang MK, Kim RH, Kim SJ, et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival [J]. Br J Cancer,2007,96(1)∶126-133 [18] 李咏,王春风,赵光叶,等.口腔黏膜癌变过程中及Bmi-1及P16蛋白的表达及意义[J].口腔医学研究,2016,32(10)∶1051-1055 [19] O’Regan EM, Toner ME, Finm SP,et al.p16(INK4A)genetic and epigenetic profiles differ in relation to age site in head and neck squamous cell carcinomas [J]. Hum Pathol,2008,39(3)∶452 [20] 付洁,宿颖,蓝爱仙,等.抑癌基因p16和p15在口腔黏膜癌前病变中的甲基化改变[J].实用口腔医学杂志,2013,29(5)∶664-667 [21] Sedghizadeh PP, Billington WD, Paxton D, et al. Is p16 positive oropharyngeal squamous cell carcinoma associated with favorable prognosis? a systematic review and meta-analysis [J]. Oral Oncology, 2016, 54∶15-27 [22] 祝磊.p16和survivin蛋白在口腔扁平苔藓及口腔鳞状细胞癌组织中的表达[J].肿瘤基础与临床,2011,24(4)∶287-288 [23] 王欣,张圃,任英红,等.口腔鳞状细胞癌microRNA参与p53调控网络的相关研究[J].现代肿瘤医学,2013,21(6)∶1372-1375 [24] 简唯求,郑家法.p53与头颈部鳞状细胞癌的关系研究进展[J].社区医学杂志,2013,11(13)∶15-17 [25] 崔贺军.口腔鳞状细胞癌与抑癌基因p53的研究进展[J].中国实用医药,2008,3(4)∶145-147 [26] 伍强云. 沉默FAP通过PTEN/PI3K/AKT和Ras/ERK途径抑制口腔鳞癌EMT[D].南方医科大学,2014 [27] 唐婉容,李丽华,喻洁,等. TGF-β1 对口腔鳞癌相关成纤维细胞 FAP 表达的影响[J].安徽医科大学学报,2017,52(9)∶1293-1297 [28] 张明宾.胸腺基质淋巴细胞生成素在OSCC中的表达及意义[D].山东大学,2013 [29] 马竹君,冯红超,宋宇峰,等.β-catenin在口腔鳞状细胞癌中的表达及临床意义[J].贵州医药,2016,40(23)∶236-238 [30] Scarpa E, Szabó A, Bibonne A,et al. Cadherin switch during EMT in neural crest cells leads to contact inhibition of locomotion via repolarization of forces [J]. Dev Cell, 2015, 34(4)∶421-434 [31] 陈钟,潘夏薇,郑晓丹.P120ctn /E-cad在口腔鳞癌细胞迁移和侵袭中的功能[J].临床口腔医学杂志,2016,32(11)∶658-661 [32] Kukreja I,Kapoor P, Deshmukh R, et al. VEGF and CD34:a correlation between tumor angiogenesis and microvessel density-an immunohistochemical study [J]. J Oral Maxillofac Pathol,2013,17(3)∶367-373 [33] Sales CB, Buim ME, Souza RO, et al. Elevated VEGFA mRNA levels in oral squamous cell carcinomas and tumor margins:a preliminary study [J]. J Oral Pathol Med,2016,45(7)∶481-485 |